What You Need to Know About “Fluoroquinolone-Associated Disability”
Fluoroquinolones such as Avelox and Levaquin are powerful antibiotics that come in many forms. Unfortunately, these drugs are commonly prescribed for sinusitis, bronchitis and other conditions that could be successfully treated with safer antibiotics. As a result, patients have reported many adverse reactions affecting the cardiovascular, musculoskeletal and nervous systems, as well as other areas of the body.
The U.S. Food and Drug Administration (FDA) has given a name to the many symptoms associated with fluoroquinolone use – “fluoroquinolone-associated disability.”
An Important Meeting
Responding to the reports of health complications associated with fluoroquinolone use, an FDA panel held a meeting on November 5. The committee explored the risk of using fluoroquinolones for routine infections.
A total of 35 people testified during the meeting, recounting the injuries they had suffered due to fluoroquinolone use. The panel determined – largely as a result of the testimony – that fluoroquinolone use for routine infections often carries more risks than benefits.
The panel voted to recommend that fluoroquinolone warning labels be revised to reflect the fact they should only be prescribed for far more serious health problems. It noted that fluoroquinolones are no more effective in treating certain infections than placebos. No specific warning label language was recommended, because that is the responsibility of the FDA.
Fluoroquinolone marketers may have contributed to the health complications suffered by many patients by promoting the drugs as a first-line defense for much less serious infections. If you have been harmed after taking a fluoroquinolone antibiotic, please get in touch with Baron & Budd. Complete our online form or call 866-508-7081 and one of our attorneys will let you know if you are eligible to take legal action.